Kraig Biocraft Laboratories Inc (KBLB)

[GTman1]

How much will that company with no production, no sales and zero revenue be worth?...to investors on the nasdaq who mostly are not dreamers...

Just off the top of my head, here are a couple biotechs that I follow that are listed on the NASDAQ that have "no production, no sales and zero revenue"

Editas
Intellia
Fate Therapeutics
Allogene
UniQure

These are jus t a couple. There are many many more listed on NASDAQ. And all of them are backed by people you call "investors on the nasdaq who mostly are not dreamers"

In fact, almost every new biotech company that has only preclinical/phase I/phase II drugs and doesn't have a product approved by FDA yet has no revs, no production, no sales. Most of these companies (especially in the gene and cell therapy space) are living off of secondaries and looking for partnerships. Most are competing in indications that have multiple players so the majority of these companies won't make it. But they still get institutional investment from your so called "investors on the nasdaq who mostly are not dreamers". Some of them will only get partnerships if their drug proceeds to phase III. I put Kraig Labs in the same category as them. Except in KBL's case, they aren't spending $50 million a quarter to pay high salaries.